BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stone JB, DeAngelis LM. Cancer-treatment-induced neurotoxicity--focus on newer treatments. Nat Rev Clin Oncol 2016;13:92-105. [PMID: 26391778 DOI: 10.1038/nrclinonc.2015.152] [Cited by in Crossref: 99] [Cited by in F6Publishing: 77] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 DiFrancesco T, Khanna A, Stubblefield MD. Clinical Evaluation and Management of Cancer Survivors with Radiation Fibrosis Syndrome. Semin Oncol Nurs 2020;36:150982. [PMID: 32008860 DOI: 10.1016/j.soncn.2019.150982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 de Oliveira AM, Paulino MV, Vieira APF, Mckinney AM, da Rocha AJ, dos Santos GT, Leite CDC, Godoy LFDS, Lucato LT. Imaging Patterns of Toxic and Metabolic Brain Disorders. RadioGraphics 2019;39:1672-95. [DOI: 10.1148/rg.2019190016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Wang TM, Shen GP, Chen MY, Zhang JB, Sun Y, He J, Xue WQ, Li XZ, Huang SY, Zheng XH, Zhang SD, Hu YZ, Qin HD, Bei JX, Ma J, Mu J, Yao Shugart Y, Jia WH. Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury. J Natl Cancer Inst 2019;111:620-8. [PMID: 30299488 DOI: 10.1093/jnci/djy150] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
4 Wu WK, Broman KK, Brownie ER, Kauffmann RM. Ipilimumab-induced Guillain-Barré Syndrome Presenting as Dysautonomia: An Unusual Presentation of a Rare Complication of Immunotherapy. Journal of Immunotherapy 2017;40:196-9. [DOI: 10.1097/cji.0000000000000167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
5 Hilton KLF, Manwani C, Boles JE, White LJ, Ozturk S, Garrett MD, Hiscock JR. The phospholipid membrane compositions of bacterial cells, cancer cell lines and biological samples from cancer patients. Chem Sci 2021;12:13273-82. [PMID: 34777745 DOI: 10.1039/d1sc03597e] [Reference Citation Analysis]
6 Nakayama S, Adachi M, Hatano M, Inahata N, Nagao T, Fukushima N. Cytosine arabinoside induces phosphorylation of histone H2AX in hippocampal neurons via a noncanonical pathway. Neurochem Int 2021;142:104933. [PMID: 33290798 DOI: 10.1016/j.neuint.2020.104933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Saito-Diaz K, Zeltner N. Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review. Clin Auton Res 2019;29:367-84. [PMID: 30631982 DOI: 10.1007/s10286-018-00587-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Zhu H, Li Y, Liu Y, Han B. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins. ChemMedChem 2019;14:1951-62. [DOI: 10.1002/cmdc.201900410] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Bernstock JD, Hoffman SE, Chen JA, Gupta S, Kappel AD, Smith TR, Chiocca EA. The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies. Viruses 2021;13:1158. [PMID: 34204248 DOI: 10.3390/v13061158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kim S. Sensory changes and lipoprotein ratios in patients with brain cancers during cancer-related therapy: A prospective cross-sectional study. Jpn J Nurs Sci 2020;17:e12315. [PMID: 31876080 DOI: 10.1111/jjns.12315] [Reference Citation Analysis]
11 Wu HT, Yu Y, Li XX, Lang XY, Gu RZ, Fan SR, Fang X, Bai JP, Lan R, Qin XY. Edaravone attenuates H2O2 or glutamate-induced toxicity in hippocampal neurons and improves AlCl3/D-galactose induced cognitive impairment in mice. Neurotoxicology 2021;85:68-78. [PMID: 34004234 DOI: 10.1016/j.neuro.2021.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Shalabi H, Wolters PL, Martin S, Toledo-Tamula MA, Roderick MC, Struemph K, Kane E, Yates B, Delbrook C, Mackall CL, Lee DW, Fry TJ, Shah NN. Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy. J Immunother 2018;41:350-8. [PMID: 30048343 DOI: 10.1097/CJI.0000000000000241] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
13 Vuattoux D, Colomer-Lahiguera S, Fernandez PA, Jequier Gygax M, Choucair ML, Beck-Popovic M, Diezi M, Manificat S, Latifyan S, Ramelet AS, Eicher M, Chabane N, Renella R. Cancer Care of Children, Adolescents and Adults With Autism Spectrum Disorders: Key Information and Strategies for Oncology Teams. Front Oncol 2020;10:595734. [PMID: 33552969 DOI: 10.3389/fonc.2020.595734] [Reference Citation Analysis]
14 Cacho-Díaz B, Lorenzana-Mendoza NA, Salmerón-Moreno K, Reyes-Soto G, Castillo-Rangel C, Corona-Cedillo R, Escobar-Ceballos S, Garza-Salazar JG. Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports. Medicine (Baltimore) 2019;98:e15691. [PMID: 31083272 DOI: 10.1097/MD.0000000000015691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Topp MS, Zimmerman Z, Kantarjian HM. Correction regarding data on blinatumomab-associated seizures. Nat Rev Clin Oncol 2016;13:650. [PMID: 27550855 DOI: 10.1038/nrclinonc.2016.133] [Reference Citation Analysis]
16 Xu D, Lu ST, Li YS, Baidya A, Mei H, He Y, Wu B. Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment. Drug Des Devel Ther 2018;12:3301-9. [PMID: 30323562 DOI: 10.2147/DDDT.S178569] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 González-Santos Á, Postigo-Martin P, Gallart-Aragón T, Esteban-Cornejo I, Lopez-Garzon M, Galiano-Castillo N, Arroyo-Morales M, Illescas-Montes R, Artacho-Cordón F, Martín-Martín L, Forneiro-Pérez R, Lozano-Lozano M, Fernández-Lao C, Ruiz-Vozmediano J, Sánchez-Salgado C, Cantarero-Villanueva I. Neurotoxicity prevention with a multimodal program (ATENTO) prior to cancer treatment versus throughout cancer treatment in women newly diagnosed for breast cancer: Protocol for a randomized clinical trial. Res Nurs Health 2021;44:598-607. [PMID: 33963594 DOI: 10.1002/nur.22136] [Reference Citation Analysis]
18 Bartley CM, Parikshak NN, Ngo TT, Alexander JA, Zorn KC, Alvarenga BA, Kang MK, Pedriali M, Pleasure SJ, Wilson MR. Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy. Front Neurol 2021;12:728700. [PMID: 34744969 DOI: 10.3389/fneur.2021.728700] [Reference Citation Analysis]
19 Dréan A, Goldwirt L, Verreault M, Canney M, Schmitt C, Guehennec J, Delattre JY, Carpentier A, Idbaih A. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma. Expert Rev Neurother 2016;16:1285-300. [PMID: 27310463 DOI: 10.1080/14737175.2016.1202761] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
20 Yamaguchi M, Tomihara K, Heshiki W, Sakurai K, Sekido K, Tachinami H, Moniruzzaman R, Inoue S, Fujiwara K, Noguchi M. Astaxanthin ameliorates cisplatin‐induced damage in normal human fibroblasts. Oral Science International 2019;16:171-7. [DOI: 10.1002/osi2.1031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Lee J, Jeong MI, Kim HR, Park H, Moon WK, Kim B. Plant Extracts as Possible Agents for Sequela of Cancer Therapies and Cachexia. Antioxidants (Basel) 2020;9:E836. [PMID: 32906727 DOI: 10.3390/antiox9090836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Lazic A, Popović J, Paunesku T, Woloschak GE, Stevanović M. Insights into platinum-induced peripheral neuropathy-current perspective. Neural Regen Res 2020;15:1623-30. [PMID: 32209761 DOI: 10.4103/1673-5374.276321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 John J, Kinra M, Mudgal J, Viswanatha GL, Nandakumar K. Animal models of chemotherapy-induced cognitive decline in preclinical drug development. Psychopharmacology (Berl) 2021;238:3025-53. [PMID: 34643772 DOI: 10.1007/s00213-021-05977-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ghai S, Ghai I. Role of Sonification and Rhythmic Auditory Cueing for Enhancing Gait Associated Deficits Induced by Neurotoxic Cancer Therapies: A Perspective on Auditory Neuroprosthetics. Front Neurol 2019;10:21. [PMID: 30761065 DOI: 10.3389/fneur.2019.00021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Stieb S, Snider JW, Placidi L, Kliebsch U, Lomax AJ, Schneider RA, Weber DC. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance. International Journal of Radiation Oncology*Biology*Physics 2018;100:218-25. [DOI: 10.1016/j.ijrobp.2017.08.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
26 Nguyen MT, Stoianovici R, Brunetti L. Chemotherapy induced stroke mimic: 5-Fluorouracil encephalopathy fulfilling criteria for tissue plasminogen activator therapy. The American Journal of Emergency Medicine 2017;35:1389-90. [DOI: 10.1016/j.ajem.2017.07.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
27 Gonzalez Castro LN, Dietrich J. Evaluation and management of chimeric antigen receptor (CAR) T-cell-associated neurotoxicity. Neurooncol Pract 2021;8:259-65. [PMID: 34055373 DOI: 10.1093/nop/npaa080] [Reference Citation Analysis]
28 Pruitt AA. Epidemiology, Treatment, and Complications of Central Nervous System Metastases. Continuum (Minneap Minn) 2017;23:1580-600. [PMID: 29200112 DOI: 10.1212/CON.0000000000000551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Hirschey R, Nance J, Hoover R, Triglianos T, Coffman E, Horrell LN, Walker J, Leak Bryant A, Valle C. Physical Activity: A Systematic Review to Inform Nurse Recommendations During Treatment for Colorectal Cancer. Clin J Oncol Nurs 2021;25:697-705. [PMID: 34800098 DOI: 10.1188/21.CJON.697-705] [Reference Citation Analysis]
30 Cooper E, Choi PJ, Denny WA, Jose J, Dragunow M, Park TI. The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors. Front Oncol 2021;11:654921. [PMID: 34141613 DOI: 10.3389/fonc.2021.654921] [Reference Citation Analysis]
31 Leng X, Qin C, Lin H, Li M, Zhao K, Wang H, Duan F, An J, Wu D, Liu Q, Qiu S. Altered Topological Properties of Static/Dynamic Functional Networks and Cognitive Function After Radiotherapy for Nasopharyngeal Carcinoma Using Resting-State fMRI. Front Neurosci 2021;15:690743. [PMID: 34335167 DOI: 10.3389/fnins.2021.690743] [Reference Citation Analysis]
32 Kelley MR, Wikel JH, Guo C, Pollok KE, Bailey BJ, Wireman R, Fishel ML, Vasko MR. Identification and Characterization of New Chemical Entities Targeting Apurinic/Apyrimidinic Endonuclease 1 for the Prevention of Chemotherapy-Induced Peripheral Neuropathy. J Pharmacol Exp Ther 2016;359:300-9. [PMID: 27608656 DOI: 10.1124/jpet.116.235283] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
33 Xia W, Hou M. Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a. Oncol Lett 2018;15:10037-46. [PMID: 29928373 DOI: 10.3892/ol.2018.8438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
34 Chiang JCB, Goldstein D, Park SB, Krishnan AV, Markoulli M. Corneal nerve changes following treatment with neurotoxic anticancer drugs. Ocul Surf 2021;21:221-37. [PMID: 34144206 DOI: 10.1016/j.jtos.2021.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Scaria B, Sood S, Raad C, Khanafer J, Jayachandiran R, Pupulin A, Grewal S, Okoko M, Arora M, Miles L, Pandey S. Natural Health Products (NHP's) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends. Int J Mol Sci 2020;21:E8480. [PMID: 33187200 DOI: 10.3390/ijms21228480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Villota H, Pizarro S, Gajardo F, Delgadillo Á, Cortés-Mancera F, Bernal G. Ruthenium Complex Induce Cell Death in G-415 Gallbladder Cancer Cells. J Gastrointest Cancer 2020;51:571-8. [PMID: 31407248 DOI: 10.1007/s12029-019-00278-x] [Reference Citation Analysis]
37 Oh Y, Shim K, Ahn C, Kim SS, Je J. Sea Squirt ( Halocynthia roretzi ) Hydrolysates Induce Apoptosis in Human Colon Cancer HT-29 Cells through Activation of Reactive Oxygen Species. Nutrition and Cancer 2019;71:118-27. [DOI: 10.1080/01635581.2018.1540717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zhang B, Li X, Yin T, Qin D, Chen Y, Ma Q, Shu P, Wang Y, Marchetti C. Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4259205] [Reference Citation Analysis]
39 Rai AC, Goyal A, Khurana AK, Vangala A. Chemotherapy as cause of refractory severe headache in a case of small-cell lung cancer. BMJ Case Rep 2021;14:e240654. [PMID: 33910796 DOI: 10.1136/bcr-2020-240654] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Schultze-Florey CR, Peczynski C, de Marino I, Polge E, Socié G, Blaise D, Beelen D, Franke GN, Kröger N, Stelljes M, Afanasyev B, Potter V, Gerbitz A, Schetelig J, Peric Z, Schoemans H, Koenecke C, Basak GW; EBMT Transplant Complications Working Party (TCWP). Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis. Bone Marrow Transplant 2020;55:1642-6. [PMID: 31695171 DOI: 10.1038/s41409-019-0738-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
41 Lee HM, Clark EP, Kuijer MB, Cushman M, Pommier Y, Philpot BD. Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome. Mol Autism 2018;9:45. [PMID: 30140420 DOI: 10.1186/s13229-018-0228-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
42 Souza-Fonseca-Guimaraes F, Blake SJ, Makkouk A, Chester C, Kohrt HE, Smyth MJ. Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity. Oncoimmunology 2016;5:e1192740. [PMID: 27622048 DOI: 10.1080/2162402X.2016.1192740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
43 Makena MR, Ranjan A, Thirumala V, Reddy AP. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165339. [PMID: 30481586 DOI: 10.1016/j.bbadis.2018.11.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
44 Alemany M, Velasco R, Simó M, Bruna J. Late effects of cancer treatment: consequences for long-term brain cancer survivors. Neurooncol Pract 2021;8:18-30. [PMID: 33664966 DOI: 10.1093/nop/npaa039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Oliveira Pinho J, Matias M, Gaspar MM. Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma. Nanomaterials (Basel) 2019;9:E1455. [PMID: 31614947 DOI: 10.3390/nano9101455] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
46 Hoeffner EG. Central Nervous System Complications of Oncologic Therapy. Hematology/Oncology Clinics of North America 2016;30:899-920. [DOI: 10.1016/j.hoc.2016.03.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
47 Helton K, Patterson AL, Khan RB, Sadighi ZS. The Complex Diagnostic Challenge in Children With Non-Central Nervous System Cancer and Cerebellar Mutism. J Child Neurol 2017;32:823-7. [PMID: 28497710 DOI: 10.1177/0883073817709178] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
48 Williams KJ, Allen RC. Immune Checkpoint Inhibitor-Induced Ptosis in a Patient With Prostate Cancer. J Neuroophthalmol 2021;41:e71-2. [PMID: 32235233 DOI: 10.1097/WNO.0000000000000927] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Briani C, Ferrari S, Campagnolo M, Tagliapietra M, Castellani F, Salvalaggio A, Mariotto S, Visentin A, Cavallaro T. Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies. Brain Sci 2021;11:132. [PMID: 33498362 DOI: 10.3390/brainsci11020132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Pagella P, Miran S, Neto E, Martin I, Lamghari M, Mitsiadis TA. Human dental pulp stem cells exhibit enhanced properties in comparison to human bone marrow stem cells on neurites outgrowth. FASEB J 2020;34:5499-511. [PMID: 32096581 DOI: 10.1096/fj.201902482R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
51 El-Agamy SE, Abdel-Aziz AK, Esmat A, Azab SS. Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemother Pharmacol 2019;84:1-14. [PMID: 30955080 DOI: 10.1007/s00280-019-03827-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
52 Sbenati RM, Zaraei SO, El-Gamal MI, Anbar HS, Tarazi H, Zoghbor MM, Mohamood NA, Khakpour MM, Zaher DM, Omar HA, Alach NN, Shehata MK, El-Gamal R. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. Eur J Med Chem 2021;210:113081. [PMID: 33310290 DOI: 10.1016/j.ejmech.2020.113081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Karthikeyan K, Babu CM, Shaji S, Ashok AM, Madhu C. Case report on 5-fluorouracil induced cerebrovascular accident. J Oncol Pharm Pract 2021;27:1016-9. [DOI: 10.1177/1078155220954900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lomeli N, Lepe J, Gupta K, Bota DA. Cognitive complications of cancer and cancer-related treatments - Novel paradigms. Neurosci Lett 2021;749:135720. [PMID: 33582187 DOI: 10.1016/j.neulet.2021.135720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Youssef G, Wen PY. Medical and Neurological Management of Brain Tumor Complications. Curr Neurol Neurosci Rep 2021;21:53. [PMID: 34545509 DOI: 10.1007/s11910-021-01142-x] [Reference Citation Analysis]
56 Iqubal A, Sharma S, Najmi AK, Syed MA, Ali J, Alam MM, Haque SE. Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF- κB. Life Sci 2019;236:116867. [PMID: 31520598 DOI: 10.1016/j.lfs.2019.116867] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
57 Campbell BA, Lasocki A, Oon SF, Bressel M, Goroncy N, Dwyer M, Wiltshire K, Seymour JF, Mason K, Tange D, Xu M, Wheeler G. Evaluation of the Impact of Magnetic Resonance Imaging with Susceptibility-weighted Imaging for Screening and Surveillance of Radiation-induced Cavernomas in Long-term Survivors of Malignancy. Clin Oncol (R Coll Radiol) 2021;33:e425-32. [PMID: 34024699 DOI: 10.1016/j.clon.2021.04.010] [Reference Citation Analysis]
58 Wu HF, Zeltner N. Overview of Methods to Differentiate Sympathetic Neurons from Human Pluripotent Stem Cells. Curr Protoc Stem Cell Biol 2019;50:e92. [PMID: 31479594 DOI: 10.1002/cpsc.92] [Reference Citation Analysis]
59 Cheong XK, Ng CF, Tan HJ, Remli R. Acute Thoracolumbar Myelitis Secondary To Intrathecal Chemotherapy. J Neurosci Rural Pract 2021;12:815-6. [PMID: 34737525 DOI: 10.1055/s-0041-1735246] [Reference Citation Analysis]
60 Kim S. A Longitudinal Study of Lipid Peroxidation and Symptom Clusters in Patients With Brain Cancers. Nursing Research 2018;67:387-94. [DOI: 10.1097/nnr.0000000000000302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Advani D, Gupta R, Tripathi R, Sharma S, Ambasta RK, Kumar P. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach. Neurochem Int 2020;140:104841. [PMID: 32853752 DOI: 10.1016/j.neuint.2020.104841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Briani C, Visentin A, Campagnolo M, Salvalaggio A, Ferrari S, Cavallaro T, Manara R, Gasparotti R, Piazza F. Peripheral nervous system involvement in lymphomas. J Peripher Nerv Syst 2019;24:5-18. [PMID: 30556258 DOI: 10.1111/jns.12295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
63 Boisselier P, Racadot S, Thariat J, Graff P, Pointreau Y. Radiothérapie conformationnelle avec modulation d’intensité des cancers des voies aérodigestives supérieures. Dose de tolérance des tissus sains : moelle épinière et plexus brachial. Cancer/Radiothérapie 2016;20:459-66. [DOI: 10.1016/j.canrad.2016.08.124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
64 Prabhakar NK, Schmidt PC. Chemotherapy Withdrawal Migraine. Pain Med 2021:pnab184. [PMID: 34100947 DOI: 10.1093/pm/pnab184] [Reference Citation Analysis]
65 Rizzo A, Santoni M, Mollica V, Logullo F, Rosellini M, Marchetti A, Faloppi L, Battelli N, Massari F. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol 2022. [PMID: 35029519 DOI: 10.1080/17425255.2021.2029405] [Reference Citation Analysis]
66 Nielsen SW, Eckhoff L, Ruhlmann CHB, Herrstedt J, Dalton SO. The prevalence, distribution and impact of peripheral neuropathy among Danish patients with cancer - a population-based cross-sectional study. Acta Oncol 2021;:1-8. [PMID: 34846991 DOI: 10.1080/0284186X.2021.2007283] [Reference Citation Analysis]
67 Zhou Y, Shen JK, Hornicek FJ, Kan Q, Duan Z. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. Oncotarget 2016;7:40846-59. [PMID: 27049727 DOI: 10.18632/oncotarget.8519] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
68 Fahim A, Rehman Z, Bhatti MF, Virk N, Ali A, Rashid A, Paracha RZ. The Route to 'Chemobrain' - Computational probing of neuronal LTP pathway. Sci Rep 2019;9:9630. [PMID: 31270411 DOI: 10.1038/s41598-019-45883-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
69 Talmor G, Nguyen B, Geller MT, Hsu J, Kaye R, Caloway C. Vocal Fold Motion Impairment Following Chemotherapy Administration: Case Reports and Review of the Literature. Ann Otol Rhinol Laryngol 2021;130:405-15. [PMID: 33501843 DOI: 10.1177/0003489421990149] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Stawicki B, Schacher T, Cho H. Nanogels as a Versatile Drug Delivery System for Brain Cancer. Gels 2021;7:63. [PMID: 34073626 DOI: 10.3390/gels7020063] [Reference Citation Analysis]
71 Sanie-Jahromi F, Saadat M. Different profiles of the mRNA levels of DNA repair genes in MCF-7 and SH-SY5Y cells after treatment with combination of cisplatin, 50-Hz electromagnetic field and bleomycin. Biomed Pharmacother 2017;94:564-8. [PMID: 28780472 DOI: 10.1016/j.biopha.2017.07.115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
72 Palmer ACS, Zortea M, Souza A, Santos V, Biazús JV, Torres ILS, Fregni F, Caumo W. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial. PLoS One 2020;15:e0231379. [PMID: 32302347 DOI: 10.1371/journal.pone.0231379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
73 Pro S, Vinti L, Boni A, Mastronuzzi A, Scilipoti M, Velardi M, Caroleo AM, Farina E, Badolato F, Alessi I, Di Nardo G, Carai A, Valeriani M, Reale A, Parisi P, Raucci U. Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies. J Clin Med 2021;10:3016. [PMID: 34300182 DOI: 10.3390/jcm10143016] [Reference Citation Analysis]
74 Velasco R, Domingo-Domenech E, Sureda A. Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy. Cancers (Basel) 2021;13:6125. [PMID: 34885234 DOI: 10.3390/cancers13236125] [Reference Citation Analysis]
75 Hanna S, Elshennawy S, El‐ayadi M, Abdelazeim F. Investigating fine motor deficits during maintenance therapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2020;67. [DOI: 10.1002/pbc.28385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Pich O, Muiños F, Lolkema MP, Steeghs N, Gonzalez-Perez A, Lopez-Bigas N. The mutational footprints of cancer therapies. Nat Genet 2019;51:1732-40. [PMID: 31740835 DOI: 10.1038/s41588-019-0525-5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 58] [Article Influence: 27.0] [Reference Citation Analysis]
77 Seiler A, Blum D, Deuel JW, Hertler C, Schettle M, Zipser CM, Ernst J, Schubert M, von Känel R, Boettger S. Delirium is associated with an increased morbidity and in-hospital mortality in cancer patients: Results from a prospective cohort study. Palliat Support Care 2021;19:294-303. [PMID: 33431093 DOI: 10.1017/S147895152000139X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Bujoreanu I, Ferguson M, Saleh H. Chemotherapy associated dural sinus thrombosis presenting as a cerebrospinal fluid leak. BMJ Case Rep 2020;13:e235240. [PMID: 32487533 DOI: 10.1136/bcr-2020-235240] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Liu K, Zhao F, Yan J, Xia Z, Jiang D, Ma P. Hispidulin: A promising flavonoid with diverse anti-cancer properties. Life Sci 2020;259:118395. [PMID: 32905830 DOI: 10.1016/j.lfs.2020.118395] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
80 Yi Z, Gao H, Ji X, Yeo XY, Chong SY, Mao Y, Luo B, Shen C, Han S, Wang JW, Jung S, Shi P, Ren H, Liu X. Mapping Drug-Induced Neuropathy through In-Situ Motor Protein Tracking and Machine Learning. J Am Chem Soc 2021;143:14907-15. [PMID: 34469145 DOI: 10.1021/jacs.1c07312] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Duong L, Radley-Crabb HG, Gardner JK, Tomay F, Dye DE, Grounds MD, Pixley FJ, Nelson DJ, Jackaman C. Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia. Front Genet 2018;9:526. [PMID: 30459812 DOI: 10.3389/fgene.2018.00526] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
82 Nolan C, DeAngelis LM. The confused oncologic patient: a rational clinical approach. Curr Opin Neurol 2016;29:789-96. [PMID: 27676278 DOI: 10.1097/WCO.0000000000000392] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
83 Chen Q, Lv X, Zhang S, Lin J, Song J, Cao B, Weng Y, Li L, Huang R. Altered properties of brain white matter structural networks in patients with nasopharyngeal carcinoma after radiotherapy. Brain Imaging Behav 2020;14:2745-61. [PMID: 31900892 DOI: 10.1007/s11682-019-00224-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
84 Hun M, Xie M, She Z, Abdirahman AS, Li C, Wu F, Luo S, Han P, Phorn R, Wu P, Luo H, Chen K, Tian J, Wan W, Wen C. Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size. Front Pediatr 2021;9:678890. [PMID: 34277519 DOI: 10.3389/fped.2021.678890] [Reference Citation Analysis]
85 Xie X, Zhang Y, Li F, Lv T, Li Z, Chen H, Jia L, Gao Y. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery. CCDT 2019;19:257-76. [DOI: 10.2174/1568009618666180628160211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
86 Lee EQ. Neurologic Complications in Patients With Cancer. Continuum (Minneap Minn) 2020;26:1629-45. [PMID: 33273175 DOI: 10.1212/CON.0000000000000937] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Thombare VJ, Holden JA, Reynolds EC, O'Brien-Simpson NM, Hutton CA. Celogentin mimetics as inhibitors of tubulin polymerization. J Pept Sci 2020;26:e3239. [PMID: 31847053 DOI: 10.1002/psc.3239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Mendes NT, Ramos de Freitas L, Lopes RP, Silva LSAD, Meneses de Oliveira FT. Reversible cerebral vasoconstriction syndrome after intrathecal cytarabine. Hematol Transfus Cell Ther 2020:S2531-1379(20)31297-9. [PMID: 33358684 DOI: 10.1016/j.htct.2020.10.961] [Reference Citation Analysis]
89 Liu S, Ono RJ, Yang C, Gao S, Ming Tan JY, Hedrick JL, Yang YY. Dual pH-Responsive Shell-Cleavable Polycarbonate Micellar Nanoparticles for in Vivo Anticancer Drug Delivery. ACS Appl Mater Interfaces 2018;10:19355-64. [PMID: 29757607 DOI: 10.1021/acsami.8b01954] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]